IDFA Endorses National Academies Report on Infant Formula Safety
The report, titled Challenges in Supply, Market Competition, and Regulation of Infant Formula in the United States, was prepared by the National Academies of Sciences, Engineering, and Medicine. Congress commissioned the assessment through the Access to Baby Formula Act of 2022.
Its recommendations are intended to support reliable nationwide availability while strengthening product safety and updating oversight of infant formula, a nutritional category supplied by a limited number of manufacturers. The study examines weaknesses highlighted by earlier supply disruptions and assigns particular importance to food safety, supply-chain resilience and cooperation among government agencies.
A central recommendation calls on the Food and Drug Administration to work with universities and commercial producers on methods for controlling Cronobacter sakazakii. The report also supports common approaches to microbial sampling, investigations into environmental contamination and faster diagnostic procedures. These measures concern a pathogen associated with serious foodborne illness in infants.
To address concentration in the domestic market, the National Academies proposes changes to state-level sole-source bidding under the Special Supplemental Nutrition Program for Women, Infants, and Children. The proposed changes are intended to reduce the effect of a primary supplier’s temporary plant shutdown on availability. The report also recommends national reserves of key formula ingredients, a shorter review process for new suppliers and temporary tariff adjustments during severe domestic shortages.
Formula producers and ingredient processors in the United States have invested hundreds of millions of dollars in operational security and additional production capacity, according to the report’s summary. Reported upgrades include clean-in-place sanitation equipment, HVAC systems divided into micro-zones with HEPA filtration, continuous testing of environmental surfaces and automated lines for powdered-product packaging.
IDFA said formula safety depends on combining strict sanitary design and pathogen controls with predictable regulation that supports further capital investment. The association’s endorsement links the dairy-processing industry to the report’s emphasis on pathogen reduction, reserve capacity and coordination among federal authorities, ingredient suppliers and dairy manufacturers.
